Search

Learn how MSK’s liquid biopsy test, MSK-ACCESS, could improve the lives of patients with gynecologic cancers.

… Wednesday, July 26, 2023 Liquid biopsies have the potential to revolutionize cancer diagnosis and treatment decisions. Unlike biopsies that require removing tumor tissue, these tests use a simple blood draw to assess the molecular characteristics of cancer. Liquid biopsies can be done repeatedly and

Scientists are decoding the genetic changes that drive individual cancer cells. This may help them develop more-effective targeted therapies.

… Tuesday, February 27, 2018 Summary Being able to find the genetic mutations that drive individual cells within a tumor may lead to better targeted therapies. Precision oncology is based on the idea that the molecular changes driving cancer can be targeted with drugs to stop a tumor from growing. But

Scientists have uncovered a molecule that, in mice, can promote the regeneration of the thymus, where T cells develop.

… Friday, January 12, 2018 Summary Scientists have identified a molecule that, in mice, can promote the regeneration of the thymus. The finding paves the way toward treatments aimed at repairing this important immune system organ. Love your thymus. This small butterfly-shaped organ in the upper chest is

The Gerstner Sloan Kettering Summer Undergraduate Research Program has welcomed 24 students to Sloan Kettering Institute labs for a ten-week course of study mentored by GSK faculty.

… Wednesday, June 11, 2014 The 2014 Gerstner Sloan Kettering Summer Undergraduate Research Program (SURP) , which will run from June 2 to August 8, includes 24 students from 21 different institutions. The students are assigned to GSK faculty mentors and will work in Sloan Kettering Institute labs learning

Hear from Abby Wood, a survivor of Hodgkin lymphoma, who is now giving back to MSK through fundraising with Cycle for Survival.

… Friday, September 28, 2018 Summary This story originally appeared in Bridges, MSK’s newsletter for cancer survivors. Bridges offers a forum in which patients and their families can share stories of inspiration and hope, and of the challenges that can accompany a cancer journey. Learn more about how to

New MSK research uses saturation genome editing to better understanding of the RAD51C gene, which has been linked to higher risks of breast and ovarian cancer; sheds new light on brain metastasis; and finds a commercially available contrast dye could help surgeons better separate cancer from healthy tissue.

… Wednesday, September 18, 2024 New research from Memorial Sloan Kettering Cancer Center (MSK) uses saturation genome editing to better understanding of the RAD51C gene, which has been linked to higher risks of breast and ovarian cancer; sheds new light on brain metastasis; and finds a commercially available

Discover the role of the work environment in the life and career of an employee with cancer.

… Wednesday, February 8, 2017 Summary Breast cancer patients who worked for supportive employers were more likely to hang onto their jobs after treatment than women who didn’t, according to a new study led by Memorial Sloan Kettering medical oncologist Victoria Blinder . Hear how one woman navigated life

Event-free survival (EFS) was 27% higher for patients with locally advanced head and neck squamous cell cancer (HNSCC) who received standard-of-care with neoadjuvant and adjuvant pembrolizumab compared to the control group who did not receive the immune checkpoint inhibitor, according to a new study published today in The New England Journal of Medicine.

… Wednesday, June 18, 2025 Event-free survival (EFS) was 27% higher for patients with locally advanced head and neck squamous cell cancer (HNSCC) who received standard-of-care with neoadjuvant and adjuvant pembrolizumab compared to the control group who did not receive the immune checkpoint inhibitor,

MSK has developed an arsenal of tests that are at the front lines of precision treatments. They target the structure of proteins that cause cancer, offering people new hope.

… Saturday, July 1, 2023 It was a major milestone a decade in the making. Inside a bustling lab at Memorial Sloan Kettering Cancer Center (MSK) on an otherwise ordinary Thursday in February 2023, specially trained technicians performed a unique test for the 100,000th time. The test was to analyze DNA from

A new study from researchers at MSK and Weill Cornell Medicine provides fresh insights about how cancers evolve when they metastasize — insights that could aid in developing strategies to improve the effectiveness of treatment.

… Monday, June 2, 2025 When cancer spreads from a primary tumor to new sites throughout the body, it undergoes changes that increase its genetic complexity. A new study from researchers at Memorial Sloan Kettering Cancer Center (MSK) and Weill Cornell Medicine provides fresh insights about how cancers